Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): Case series

Journal of Psychopharmacology

Volumn 23, Issue 8, 2009, Pages 985-987

  Juruena, M F ^a   Gama, C S ^b,c   Berk, M ^c   Belmonte De Abreu, P S ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bipolar disorder; HPA axis; Mineralocorticoid antagonist; Residual symptoms; Serotonin

Indexed keywords

CITALOPRAM; CLOZAPINE; LAMOTRIGINE; QUETIAPINE; SPIRONOLACTONE; VALPROIC ACID;

ADD ON THERAPY; ADULT; ANTICIPATORY ANXIETY; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CASE STUDY; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; LETHARGY; MALE; MENTAL PATIENT; MENTAL STRESS; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; BIPOLAR DISORDER; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE; STRESS, PSYCHOLOGICAL;

EID: 70449331563     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108092121     Document Type: Article

References (17)

1. Bendtzen, K., Hansen, PR, Rieneck, K. ; The Spironolactone/Arthritis Study Group (2003) Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis. Clin Exp Immunol 134: 151-158.
2. Cervilla, JA, Molina, E., Rivera, M., Torres-Gonzélez, F., Bellón, JA, Moreno, B., et al. (2007) The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-Gene cohort. Mol Psychiatry 12: 748-755.
3. Deakin, JFW, Graeff, FG (1991) 5-HT and mechanisms of defence. J Psychopharmacol 5: 305-315.
4. de Kloet, ER, Joels, M., Holsboer, F. (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6: 463-475.
5. de Kloet, ER, Vreugdenhil, E., Oitzl, MS, Joels, M. (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19: 269-301.
6. Heuser, I., Deuschle, M., Weber, B., Stalla, GK, Holsboer, F. (2000) Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 25: 513-518.
7. Juruena, MF, Cleare, AJ, Bauer, ME, Pariante, CM (2003) Molecular mechanism of GR sensitivity and relevance for affective disorders, for special issue. Acta Neuropsychiatrica 15: 354-367.
8. Juruena, MF, Cleare, AJ, Papadopoulos, AS, Poon, L., Lightman, S., Pariante, CM (2006) Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology (Berl) 189: 225-235.
9. Lopez, JF, Chalmers, DT, Little, KY, Watson, SJ ; A.E. Bennett Research Award (1998) Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43: 547-573.
10. McEwen, BS (2000) Allostasis and allostatic load: implications for neuropsychopharmaco-logy. Neuropsychopharmacology 22: 108-124.
11. Myin-Germeys, I., Peeters, F., Havermans, R., Nicolson, NA, deVries, MW, Delespaul, P., et al. (2003) Emotional reactivity to daily life stress in psychosis and affective disorder: an experience sampling study. Acta Psychiatr Scand 107: 124-131. (Pubitemid 36164480)
12. Pariante, CM (2008) The role of multi-drug resistance p-glycoprotein in glucocorticoid function: Studies in animals and relevance in humans. Eur J Pharmacol, in press.
13. Reul, JM, de Kloet, ER (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117: 2505-2511.
14. Semont, A., Fache, M., Ouafik, L., Hery, M., Faudon, M., Hery, F. (1999) Effect of serotonin inhibition on glucocorticoid and mineralocorticoid expression in various brain structure. Neuroendocrinology 69: 121-128.
15. Storey, JD, Balfour, DJK (2002) The influence of repetitive stress on hippocampal 5-HT overflow and plus maze activity in the rat. Br J Pharmacol 137: 143.
16. Webster, MJ, Knable, MB, OGrady, J., Orthmann, J., Weickert, CS (2002) Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 7: 985-994, 924.
17. Young, EA, Lopez, JF, Murphy-Weinberg, V., Watson, SJ, Akil, H. (2003) Mineralocorticoid receptor function in major depresi3n. Arch Gen Psychiatry 60: 24-28.